Effect of Pharmacist Clinic Visits on 30-Day Heart Failure Readmission Rates at a County Hospital

Lucy Hahn, Matthew Belisle, Sarah Nguyen, Kristin Snackey Alvarez, Sandeep R Das

Research output: Contribution to journalArticle

Abstract

Purpose: This study evaluated the comparative effectiveness of different pharmacist visit types on reducing readmission rates. Method: A single-center, retrospective cohort study was conducted from January 2015 to July 2017. Patients were 18 years or older with an index heart failure (HF) exacerbation admission. Upon hospital discharge, patients were seen in clinic by a clinical pharmacy specialist (CPS) with collaborative practice agreement (CPA) (High Intensity Bundle), medication therapy management (MTM) pharmacist without CPA (Low Intensity Bundle), or no pharmacist (Standard of Care [SOC]). The primary outcome was 30-day all-cause readmission rate. Secondary outcomes included rate of 30-day HF readmissions and average number of days until readmission in those who were readmitted. Results: Totally, 98 patients were included in the final analysis (35 High Intensity Bundle, 28 Low Intensity Bundle, and 35 SOC). The primary outcome of all-cause readmissions was lower in both the pharmacist groups compared with SOC (CPS 8.6% [3/35] vs SOC 25.7% [9/35], P = 0.046 and MTM 7.1% [2/28] vs SOC 25.7% [9/35], P = 0.057). Incremental differences were seen between visit types for the secondary outcome of 30-day HF readmissions (CPS 2.9% vs MTM 7.1% vs SOC 17.1%, P = 0.039). The average number of days until readmission was longer in the CPS versus the MTM and SOC (26.7 days vs 12.5 days vs 14.1 days, respectively). Conclusion: Post-hospital discharge pharmacist visits were associated with lower 30-day all-cause readmission. In particular, clinic visits with a Higher Intensity Bundle may be more effective in reducing HF readmissions. These exploratory findings warrant further investigation.

Original languageEnglish (US)
JournalHospital Pharmacy
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

County Hospitals
Standard of Care
Ambulatory Care
Pharmacists
Medication Therapy Management
Heart Failure
Cohort Studies
Retrospective Studies

Keywords

  • ambulatory services
  • cardiovascular
  • clinical services
  • disease management
  • medication therapy management (MTM)

ASJC Scopus subject areas

  • Pharmacy
  • Pharmacology
  • Pharmacology (medical)

Cite this

Effect of Pharmacist Clinic Visits on 30-Day Heart Failure Readmission Rates at a County Hospital. / Hahn, Lucy; Belisle, Matthew; Nguyen, Sarah; Snackey Alvarez, Kristin; Das, Sandeep R.

In: Hospital Pharmacy, 01.01.2018.

Research output: Contribution to journalArticle

Hahn, Lucy ; Belisle, Matthew ; Nguyen, Sarah ; Snackey Alvarez, Kristin ; Das, Sandeep R. / Effect of Pharmacist Clinic Visits on 30-Day Heart Failure Readmission Rates at a County Hospital. In: Hospital Pharmacy. 2018.
@article{2349773cbca64d2da1db28f3df039aeb,
title = "Effect of Pharmacist Clinic Visits on 30-Day Heart Failure Readmission Rates at a County Hospital",
abstract = "Purpose: This study evaluated the comparative effectiveness of different pharmacist visit types on reducing readmission rates. Method: A single-center, retrospective cohort study was conducted from January 2015 to July 2017. Patients were 18 years or older with an index heart failure (HF) exacerbation admission. Upon hospital discharge, patients were seen in clinic by a clinical pharmacy specialist (CPS) with collaborative practice agreement (CPA) (High Intensity Bundle), medication therapy management (MTM) pharmacist without CPA (Low Intensity Bundle), or no pharmacist (Standard of Care [SOC]). The primary outcome was 30-day all-cause readmission rate. Secondary outcomes included rate of 30-day HF readmissions and average number of days until readmission in those who were readmitted. Results: Totally, 98 patients were included in the final analysis (35 High Intensity Bundle, 28 Low Intensity Bundle, and 35 SOC). The primary outcome of all-cause readmissions was lower in both the pharmacist groups compared with SOC (CPS 8.6{\%} [3/35] vs SOC 25.7{\%} [9/35], P = 0.046 and MTM 7.1{\%} [2/28] vs SOC 25.7{\%} [9/35], P = 0.057). Incremental differences were seen between visit types for the secondary outcome of 30-day HF readmissions (CPS 2.9{\%} vs MTM 7.1{\%} vs SOC 17.1{\%}, P = 0.039). The average number of days until readmission was longer in the CPS versus the MTM and SOC (26.7 days vs 12.5 days vs 14.1 days, respectively). Conclusion: Post-hospital discharge pharmacist visits were associated with lower 30-day all-cause readmission. In particular, clinic visits with a Higher Intensity Bundle may be more effective in reducing HF readmissions. These exploratory findings warrant further investigation.",
keywords = "ambulatory services, cardiovascular, clinical services, disease management, medication therapy management (MTM)",
author = "Lucy Hahn and Matthew Belisle and Sarah Nguyen and {Snackey Alvarez}, Kristin and Das, {Sandeep R}",
year = "2018",
month = "1",
day = "1",
doi = "10.1177/0018578718797263",
language = "English (US)",
journal = "Hospital Pharmacy",
issn = "0018-5787",
publisher = "Facts and Comparisons",

}

TY - JOUR

T1 - Effect of Pharmacist Clinic Visits on 30-Day Heart Failure Readmission Rates at a County Hospital

AU - Hahn, Lucy

AU - Belisle, Matthew

AU - Nguyen, Sarah

AU - Snackey Alvarez, Kristin

AU - Das, Sandeep R

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Purpose: This study evaluated the comparative effectiveness of different pharmacist visit types on reducing readmission rates. Method: A single-center, retrospective cohort study was conducted from January 2015 to July 2017. Patients were 18 years or older with an index heart failure (HF) exacerbation admission. Upon hospital discharge, patients were seen in clinic by a clinical pharmacy specialist (CPS) with collaborative practice agreement (CPA) (High Intensity Bundle), medication therapy management (MTM) pharmacist without CPA (Low Intensity Bundle), or no pharmacist (Standard of Care [SOC]). The primary outcome was 30-day all-cause readmission rate. Secondary outcomes included rate of 30-day HF readmissions and average number of days until readmission in those who were readmitted. Results: Totally, 98 patients were included in the final analysis (35 High Intensity Bundle, 28 Low Intensity Bundle, and 35 SOC). The primary outcome of all-cause readmissions was lower in both the pharmacist groups compared with SOC (CPS 8.6% [3/35] vs SOC 25.7% [9/35], P = 0.046 and MTM 7.1% [2/28] vs SOC 25.7% [9/35], P = 0.057). Incremental differences were seen between visit types for the secondary outcome of 30-day HF readmissions (CPS 2.9% vs MTM 7.1% vs SOC 17.1%, P = 0.039). The average number of days until readmission was longer in the CPS versus the MTM and SOC (26.7 days vs 12.5 days vs 14.1 days, respectively). Conclusion: Post-hospital discharge pharmacist visits were associated with lower 30-day all-cause readmission. In particular, clinic visits with a Higher Intensity Bundle may be more effective in reducing HF readmissions. These exploratory findings warrant further investigation.

AB - Purpose: This study evaluated the comparative effectiveness of different pharmacist visit types on reducing readmission rates. Method: A single-center, retrospective cohort study was conducted from January 2015 to July 2017. Patients were 18 years or older with an index heart failure (HF) exacerbation admission. Upon hospital discharge, patients were seen in clinic by a clinical pharmacy specialist (CPS) with collaborative practice agreement (CPA) (High Intensity Bundle), medication therapy management (MTM) pharmacist without CPA (Low Intensity Bundle), or no pharmacist (Standard of Care [SOC]). The primary outcome was 30-day all-cause readmission rate. Secondary outcomes included rate of 30-day HF readmissions and average number of days until readmission in those who were readmitted. Results: Totally, 98 patients were included in the final analysis (35 High Intensity Bundle, 28 Low Intensity Bundle, and 35 SOC). The primary outcome of all-cause readmissions was lower in both the pharmacist groups compared with SOC (CPS 8.6% [3/35] vs SOC 25.7% [9/35], P = 0.046 and MTM 7.1% [2/28] vs SOC 25.7% [9/35], P = 0.057). Incremental differences were seen between visit types for the secondary outcome of 30-day HF readmissions (CPS 2.9% vs MTM 7.1% vs SOC 17.1%, P = 0.039). The average number of days until readmission was longer in the CPS versus the MTM and SOC (26.7 days vs 12.5 days vs 14.1 days, respectively). Conclusion: Post-hospital discharge pharmacist visits were associated with lower 30-day all-cause readmission. In particular, clinic visits with a Higher Intensity Bundle may be more effective in reducing HF readmissions. These exploratory findings warrant further investigation.

KW - ambulatory services

KW - cardiovascular

KW - clinical services

KW - disease management

KW - medication therapy management (MTM)

UR - http://www.scopus.com/inward/record.url?scp=85059527538&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059527538&partnerID=8YFLogxK

U2 - 10.1177/0018578718797263

DO - 10.1177/0018578718797263

M3 - Article

C2 - 31762482

AN - SCOPUS:85059527538

JO - Hospital Pharmacy

JF - Hospital Pharmacy

SN - 0018-5787

ER -